Targeting quorum sensing in Pseudomonas aeruginosa biofilms: Current and emerging inhibitors

Future Microbiology

Volumn 8, Issue 7, 2013, Pages 901-921

  Jakobsen, Tim Holm ^a   Bjarnsholt, Thomas ^a,b   Jensen, Peter Ostrup ^b   Givskov, Michael ^a,c   Høiby, Niels ^a,b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b University of Copenhagen   (Denmark)

^c NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

Author keywords

acyl homoserine lactone signals; biofilm; Pseudomonas aeruginosa; quorum sensing; quorum sensing inhibitors; resistance; signal molecules; tolerance

Indexed keywords

AJOENE; AMINOGLYCOSIDE; AURANTIIN; AZITHROMYCIN; BAICALIN; CEFTAZIDIME; CHLOROACETAMIDE; CHLORZOXAZONE; CIPROFLOXACIN; ERUCIN; IBERIN; ISOTHIOCYANIC ACID; NICLOSAMIDE; NIFUROXAZIDE; PATULIN; PENICILLIC ACID; ROSMARINIC ACID; SULFORAPHANE; TOBRAMYCIN; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; BIOFILM; CELL COMMUNICATION; CLINICAL TRIAL (TOPIC); CYSTIC FIBROSIS; DRUG STRUCTURE; GARLIC; HUMAN; INFECTION; NONHUMAN; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; QUORUM SENSING; REVIEW; URINARY TRACT INFECTION; VIRULENCE;

ANIMALS; ANTI-BACTERIAL AGENTS; BIOFILMS; CYSTIC FIBROSIS; HUMANS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; QUORUM SENSING;

EID: 84880127165     PISSN: 17460913     EISSN: 17460921     Source Type: Journal    
DOI: 10.2217/fmb.13.57     Document Type: Review

References (188)

1. Nealson KH, Platt T, Hastings JW. Cellular control of the synthesis and activity of the bacterial luminescent system. J. Bacteriol. 104(1), 313-322 (1970).
2. Bjarnsholt T, Givskov M. The role of quorum sensing in the pathogenicity of the cunning aggressor Pseudomonas aeruginosa. Anal. Bioanal. Chem. 387(2), 409-414 (2007).
3. Costerton JW. Introduction to biofilm. Int. J. Antimicrob. Agents 11(3-4), 217-221; discussion 237-219 (1999).
4. Costerton JW, Lewandowski Z, Caldwell DE, Korber DR, Lappin-Scott HM. Microbial biofilms. Annu. Rev. Microbiol. 49, 711-745 (1995).
5. Potera C. Studying slime. Environ. Health Persp. 106(12), A604-A606 (1998).
6. Hoiby N, Bjarnsholt T, Givskov M, Molin S, Ciofu O. Antibiotic resistance of bacterial biofilms. Int. J. Antimicrob. Agents 35(4), 322-332 (2010).
7. Gomez MI, Prince A. Opportunistic infections in lung disease: Pseudomonas infections in cystic fibrosis. Curr. Opin. Pharmacol. 7(3), 244-251 (2007).
8. Stover CK, Pham XQ, Erwin AL et al. Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature 406(6799), 959-964 (2000).
9. Hassett DJ, Cuppoletti J, Trapnell B et al. Anaerobic metabolism and quorum sensing by Pseudomonas aeruginosa biofilms in chronically infected cystic fibrosis airways: rethinking antibiotic treatment strategies and drug targets. Adv. Drug Deliv. Rev. 54(11), 1425-1443 (2002).
10. Lyczak JB, Cannon CL, Pier GB. Establishment of Pseudomonas aeruginosa infection: lessons from a versatile opportunist. Microbes Infect. 2(9), 1051-1060 (2000).
11. Obritsch MD, Fish DN, MacLaren R, Jung R. Nosocomial infections due to multidrug-resistant Pseudomonas aeruginosa: epidemiology and treatment options. Pharmacotherapy 25(10), 1353-1364 (2005).
12. Woodward TC, Brown R, Sacco P, Zhang J. Budget impact model of tobramycin inhalation solution for treatment of Pseudomonas aeruginosa in cystic fibrosis patients. J. Med. Econ. 13(3), 492-499 (2010).
13. Koch C, Hoiby N. Pathogenesis of cystic fibrosis. Lancet 341(8852), 1065-1069 (1993).
14. Taga ME, Bassler BL. Chemical communication among bacteria. Proc. Natl Acad. Sci. USA 100(Suppl. 2), S14549-S14554 (2003).
15. Fuqua C, Parsek MR, Greenberg EP. Regulation of gene expression by cell-to-cell communication: acyl-homoserine lactone quorum sensing. Annu. Rev. Genet. 35, 439-468 (2001).
16. Fuqua C, Greenberg EP. Listening in on bacteria: acyl-homoserine lactone signalling. Nat. Rev. Mol. Cell Biol. 3(9), 685-695 (2002).
17. Miller MB, Bassler BL. Quorum sensing in bacteria. Annu. Rev. Microbiol. 55, 165-199 (2001).
18. Fuqua WC, Winans SC, Greenberg EP. Quorum sensing in bacteria: the LuxR-LuxI family of cell density-responsive transcriptional regulators. J. Bacteriol. 176(2), 269-275 (1994).
19. Pearson JP, Gray KM, Passador L et al. Structure of the autoinducer required for expression of Pseudomonas aeruginosa virulence genes. Proc. Natl Acad. Sci. USA 91(1), 197-201 (1994).
20. Pearson JP, Passador L, Iglewski BH, Greenberg EP. A second N-acylhomoserine lactone signal produced by Pseudomonas aeruginosa. Proc. Natl Acad. Sci. USA 92(5), 1490-1494 (1995).
21. Pesci EC, Milbank JB, Pearson JP et al. Quinolone signaling in the cell-to-cell communication system of Pseudomonas aeruginosa. Proc. Natl Acad. Sci. USA 96(20), 11229-11234 (1999).
22. Deziel E, Lepine F, Milot S et al. Analysis of Pseudomonas aeruginosa 4-hydroxy-2-alkylquinolines (HAQs) reveals a role for 4-hydroxy-2- heptylquinoline in cell-to-cell communication. Proc. Natl Acad. Sci. USA 101(5), 1339-1344 (2004).
23. Wade DS, Calfee MW, Rocha ER et al. Regulation of Pseudomonas quinolone signal synthesis in Pseudomonas aeruginosa. J. Bacteriol. 187(13), 4372-4380 (2005).
24. Gallagher LA, McKnight SL, Kuznetsova MS, Pesci EC, Manoil C. Functions required for extracellular quinolone signaling by Pseudomonas aeruginosa. J. Bacteriol. 184(23), 6472-6480 (2002).
25. McGrath S, Wade DS, Pesci EC. Dueling quorum sensing systems in Pseudomonas aeruginosa control the production of the Pseudomonas quinolone signal (PQS). FEMS Microbiol. Lett. 230(1), 27-34 (2004).
26. Xiao G, He J, Rahme LG. Mutation analysis of the Pseudomonas aeruginosa mvfR and pqsABCDE gene promoters demonstrates complex quorum-sensing circuitry. Microbiology 152(Pt 6), 1679-1686 (2006).
27. Diggle SP, Winzer K, Chhabra SR, Worrall KE, Camara M, Williams P. The Pseudomonas aeruginosa quinolone signal molecule overcomes the cell density-dependency of the quorum sensing hierarchy, regulates rhl-dependent genes at the onset of stationary phase and can be produced in the absence of LasR. Mol. Microbiol. 50(1), 29-43 (2003).
28. Juhas M, Eberl L, Tummler B. Quorum sensing: the power of cooperation in the world of Pseudomonas. Environ. Microbiol. 7(4), 459-471 (2005).
29. Pesci EC, Pearson JP, Seed PC, Iglewski BH. Regulation of las and rhl quorum sensing in Pseudomonas aeruginosa. J. Bacteriol. 179(10), 3127-3132 (1997).
30. Schuster M, Lostroh CP, Ogi T, Greenberg EP. Identification, timing, and signal specificity of Pseudomonas aeruginosa quorum-controlled genes: a transcriptome analysis. J. Bacteriol. 185(7), 2066-2079 (2003).
31. Hentzer M, Wu H, Andersen JB et al. Attenuation of Pseudomonas aeruginosa virulence by quorum sensing inhibitors. EMBO J. 22(15), 3803-3815 (2003).
32. Wagner VE, Bushnell D, Passador L, Brooks AI, Iglewski BH. Microarray analysis of Pseudomonas aeruginosa quorum-sensing regulons: effects of growth phase and environment. J. Bacteriol. 185(7), 2080-2095 (2003).
33. Howe TR, Iglewski BH. Isolation and characterization of alkaline protease-deficient mutants of Pseudomonas aeruginosa in vitro and in a mouse eye model. Infect. Immun. 43(3), 1058-1063 (1984).
34. Woods DE, Cryz SJ, Friedman RL, Iglewski BH. Contribution of toxin A and elastase to virulence of Pseudomonas aeruginosa in chronic lung infections of rats. Infect. Immun. 36(3), 1223-1228 (1982).
35. Vasil ML, Grant CC, Prince RW. Regulation of exotoxin A synthesis in Pseudomonas aeruginosa: characterization of toxA-lacZ fusions in wild-type and mutant strains. Mol. Microbiol. 3(3), 371-381 (1989).
36. Nicas TI, Frank DW, Stenzel P, Lile JD, Iglewski BH. Role of exoenzyme S in chronic Pseudomonas aeruginosa lung infections. Eur. J. Clin. Microbiol. 4(2), 175-179 (1985).
37. Cox CD. Effect of pyochelin on the virulence of Pseudomonas aeruginosa. Infect. Immun. 36(1), 17-23 (1982).
38. Jensen PO, Bjarnsholt T, Phipps R et al. Rapid necrotic killing of polymorphonuclear leukocytes is caused by quorum-sensing-controlled production of rhamnolipid by Pseudomonas aeruginosa. Microbiology 153(Pt 5), 1329-1338 (2007).
39. McClure CD, Schiller NL. Effects of Pseudomonas aeruginosa rhamnolipids on human monocyte-derived macrophages. J. Leukocyte Biol. 51(2), 97-102 (1992).
40. Shryock T, Silver S, Banschbach M, Kramer J. Effect of Pseudomonas aeruginosa rhamnolipid on human neutrophil migration. Curr. Microbiol. 10(6), 323-328 (1984).
41. Déziel E, Lépine F, Milot S, Villemur R. rhlA is required for the production of a novel biosurfactant promoting swarming motility in Pseudomonas aeruginosa: 3-(3-hydroxyalkanoyloxy)alkanoic acids (HAAs), the precursors of rhamnolipids. Microbiology 149(Pt 8), 2005-2013 (2003).
42. Hentzer M, Eberl L, Givskov M. Transcriptome analysis of Pseudomonas aeruginosa biofilm development: anaerobic respiration and iron limitation. Biofilms 2(1), 37-61 (2005).
43. Williams P, Camara M. Quorum sensing and environmental adaptation in Pseudomonas aeruginosa: a tale of regulatory networks and multifunctional signal molecules. Curr. Opin. Microbiol. 12(2), 182-191 (2009).
44. Schuster M, Greenberg EP. A network of networks: quorum-sensing gene regulation in Pseudomonas aeruginosa. Int J. Med. Microbiol. 296(2-3), 73-81 (2006).
45. Lequette Y, Lee JH, Ledgham F, Lazdunski A, Greenberg EP. A distinct QscR regulon in the Pseudomonas aeruginosa quorum-sensing circuit. J. Bacteriol. 188(9), 3365-3370 (2006).
46. Chugani SA, Whiteley M, Lee KM, D'Argenio D, Manoil C, Greenberg EP. QscR, a modulator of quorum-sensing signal synthesis and virulence in Pseudomonas aeruginosa. Proc. Natl Acad. Sci. USA 98(5), 2752-2757 (2001).
47. Ledgham F, Ventre I, Soscia C, Foglino M, Sturgis JN, Lazdunski A. Interactions of the quorum sensing regulator QscR: interaction with itself and the other regulators of Pseudomonas aeruginosa LasR and RhlR. Mol. Microbiol. 48(1), 199-210 (2003).
48. Lee JH, Lequette Y, Greenberg EP. Activity of purified QscR, a Pseudomonas aeruginosa orphan quorum-sensing transcription factor. Mol. Microbiol. 59(2), 602-609 (2006).
49. Juhas M, Wiehlmann L, Huber B et al. Global regulation of quorum sensing and virulence by VqsR in Pseudomonas aeruginosa. Microbiology 150(Pt 4), 831-841 (2004).
50. Li LL, Malone JE, Iglewski BH. Regulation of the Pseudomonas aeruginosa quorum-sensing regulator VqsR. J. Bacteriol. 189(12), 4367-4374 (2007).
51. Liang H, Deng X, Ji Q, Sun F, Shen T, He C. The Pseudomonas aeruginosa global regulator VqsR directly inhibits QscR to control quorum-sensing and virulence gene expression. J. Bacteriol. 194(12), 3098-3108 (2012).
52. Albus AM, Pesci EC, Runyen-Janecky LJ, West SE, Iglewski BH. Vfr controls quorum sensing in Pseudomonas aeruginosa. J. Bacteriol. 179(12), 3928-3935 (1997).
53. West SE, Sample AK, Runyen-Janecky LJ. The vfr gene product, required for Pseudomonas aeruginosa exotoxin A and protease production, belongs to the cyclic AMP receptor protein family. J. Bacteriol. 176(24), 7532-7542 (1994).
54. Croda-Garcia G, Grosso-Becerra V, Gonzalez-Valdez A, Servin-Gonzalez L, Soberon-Chavez G. Transcriptional regulation of Pseudomonas aeruginosa rhlR: role of the CRP orthologue Vfr (virulence factor regulator) and quorum-sensing regulators LasR and RhlR. Microbiology 157(Pt 9), 2545-2555 (2011).
55. Rampioni G, Schuster M, Greenberg EP et al. RsaL provides quorum sensing homeostasis and functions as a global regulator of gene expression in Pseudomonas aeruginosa. Mol. Microbiol. 66(6), 1557-1565 (2007).
56. Venturi V, Rampioni G, Pongor S, Leoni L. The virtue of temperance: built-in negative regulators of quorum sensing in Pseudomonas. Mol. Microbiol. 82(5), 1060-1070 (2011).
57. Reimmann C, Beyeler M, Latifi A et al. The global activator GacA of Pseudomonas aeruginosa PAO positively controls the production of the autoinducer N-butyryl-homoserine lactone and the formation of the virulence factors pyocyanin, cyanide, and lipase. Mol. Microbiol. 24(2), 309-319 (1997).
58. Kay E, Humair B, Denervaud V et al. Two GacA-dependent small RNAs modulate the quorum-sensing response in Pseudomonas aeruginosa. J. Bacteriol. 188(16), 6026-6033 (2006).
59. Pessi G, Williams F, Hindle Z et al. The global posttranscriptional regulator RsmA modulates production of virulence determinants and N-acylhomoserine lactones in Pseudomonas aeruginosa. J. Bacteriol. 183(22), 6676-6683 (2001).
60. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science 284(5418), 1318-1322 (1999).
61. O'Toole G, Kaplan HB, Kolter R. Biofilm formation as microbial development. Annu. Rev. Microbiol. 54, 49-79 (2000).
62. Sauer K. The genomics and proteomics of biofilm formation. Genome Biol. 4(6), 219 (2003).
63. Purevdorj B, Costerton JW, Stoodley P. Influence of hydrodynamics and cell signaling on the structure and behavior of Pseudomonas aeruginosa biofilms. Appl. Environ. Microbiol. 68(9), 4457-4464 (2002).
64. Reimmann C, Ginet N, Michel L et al. Genetically programmed autoinducer destruction reduces virulence gene expression and swarming motility in Pseudomonas aeruginosa PAO1. Microbiology 148(Pt 4), 923-932 (2002).
65. Klausen M, Heydorn A, Ragas P et al. Biofilm formation by Pseudomonas aeruginosa wild type, flagella and type IV pili mutants. Mol. Microbiol. 48(6), 1511-1524 (2003).
66. O'Toole GA, Kolter R. Flagellar and twitching motility are necessary for Pseudomonas aeruginosa biofilm development. Mol. Microbiol. 30(2), 295-304 (1998).
67. Flemming HC, Wingender J. The biofilm matrix. Nat. Rev. Microbiol. 8(9), 623-633 (2010).
68. Allesen-Holm M, Barken KB, Yang L et al. A characterization of DNA release in Pseudomonas aeruginosa cultures and biofilms. Mol. Microbiol. 59(4), 1114-1128 (2006).
69. Yang L, Barken KB, Skindersoe ME, Christensen AB, Givskov M, Tolker-Nielsen T. Effects of iron on DNA release and biofilm development by Pseudomonas aeruginosa. Microbiology 153(Pt 5), 1318-1328 (2007).
70. Yang L, Nilsson M, Gjermansen M, Givskov M, Tolker-Nielsen T. Pyoverdine and PQS mediated subpopulation interactions involved in Pseudomonas aeruginosa biofilm formation. Mol. Microbiol. 74(6), 1380-1392 (2009).
71. Walker TS, Tomlin KL, Worthen GS et al. Enhanced Pseudomonas aeruginosa biofilm development mediated by human neutrophils. Infect. Immun. 73(6), 3693-3701 (2005).
72. Davies DG, Parsek MR, Pearson JP, Iglewski BH, Costerton JW, Greenberg EP. The involvement of cell-to-cell signals in the development of a bacterial biofilm. Science 280(5361), 295-298 (1998).
73. Heydorn A, Ersboll B, Kato J et al. Statistical analysis of Pseudomonas aeruginosa biofilm development: impact of mutations in genes involved in twitching motility, cell-to-cell signaling, and stationary-phase s factor expression. Appl. Environ. Microbiol. 68(4), 2008-2017 (2002).
74. Bjarnsholt T, Jensen PO, Burmolle M et al. Pseudomonas aeruginosa tolerance to tobramycin, hydrogen peroxide and polymorphonuclear leukocytes is quorum-sensing dependent. Microbiology 151(Pt 2), 373-383 (2005).
75. Kirisits MJ, Margolis JJ, Purevdorj-Gage BL et al. Influence of the hydrodynamic environment on quorum sensing in Pseudomonas aeruginosa biofilms. J. Bacteriol. 189(22), 8357-8360 (2007).
76. Stoodley P, Jacobsen A, Dunsmore BC et al. The influence of fluid shear and AICI3 on the material properties of Pseudomonas aeruginosa PAO1 and Desulfovibrio sp. EX265 biofilms. Water Sci. Technol. 43(6), 113-120 (2001).
77. Kirisits MJ, Parsek MR. Does Pseudomonas aeruginosa use intercellular signalling to build biofilm communities? Cell Microbiol. 8(12), 1841-1849 (2006).
78. Shrout JD, Chopp DL, Just CL, Hentzer M, Givskov M, Parsek MR. The impact of quorum sensing and swarming motility on Pseudomonas aeruginosa biofilm formation is nutritionally conditional. Mol. Microbiol. 62(5), 1264-1277 (2006).
79. Bollinger N, Hassett DJ, Iglewski BH, Costerton JW, McDermott TR. Gene expression in Pseudomonas aeruginosa: evidence of iron override effects on quorum sensing and biofilm-specific gene regulation. J. Bacteriol. 183(6), 1990-1996 (2001).
80. Whiteley M, Bangera MG, Bumgarner RE et al. Gene expression in Pseudomonas aeruginosa biofilms. Nature 413(6858), 860-864 (2001).
81. De Kievit TR, Gillis R, Marx S, Brown C, Iglewski BH. Quorum-sensing genes in Pseudomonas aeruginosa biofilms: their role and expression patterns. Appl. Environ. Microbiol. 67(4), 1865-1873 (2001).
82. Folsom JP, Richards L, Pitts B et al. Physiology of Pseudomonas aeruginosa in biofilms as revealed by transcriptome analysis. BMC Microbiol. 10, 294 (2010).
83. Lequette Y, Greenberg EP. Timing and localization of rhamnolipid synthesis gene expression in Pseudomonas aeruginosa biofilms. J. Bacteriol. 187(1), 37-44 (2005).
84. Davey ME, Caiazza NC, O'Toole GA. Rhamnolipid surfactant production affects biofilm architecture in Pseudomonas aeruginosa PAO1. J. Bacteriol. 185(3), 1027-1036 (2003).
85. Sakuragi Y, Kolter R. Quorum-sensing regulation of the biofilm matrix genes (pel ) of Pseudomonas aeruginosa. J. Bacteriol. 189(14), 5383-5386 (2007).
86. Ueda A, Wood TK. Connecting quorum sensing, c-di-GMP, pel polysaccharide, and biofilm formation in Pseudomonas aeruginosa through tyrosine phosphatase TpbA (PA3885). PLoS Pathog. 5(6), e1000483 (2009).
87. Bjarnsholt T, Jensen PO, Fiandaca MJ et al. Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients. Pediatr. Pulmonol. 44(6), 547-558 (2009).
88. Gottrup F. A specialized wound-healing center concept: importance of a multidisciplinary department structure and surgical treatment facilities in the treatment of chronic wounds. Am. J. Surg. 187(5A), 38S-43S (2004).
89. Bjarnsholt T, Kirketerp-Moller K, Jensen PO et al. Why chronic wounds will not heal: a novel hypothesis. Wound Repair. Regen. 16(1), 2-10 (2008).
90. Fazli M, Bjarnsholt T, Kirketerp-Moller K et al. Nonrandom distribution of Pseudomonas aeruginosa and Staphylococcus aureus in chronic wounds. J. Clin. Microbiol. 47(12), 4084-4089 (2009).
91. James GA, Swogger E, Wolcott R et al. Biofilms in chronic wounds. Wound Repair. Regen. 16(1), 37-44 (2008).
92. Kirketerp-Moller K, Jensen PO, Fazli M et al. Distribution, organization, and ecology of bacteria in chronic wounds. J. Clin. Microbiol. 46(8), 2717-2722 (2008).
93. Gjodsbol K, Christensen JJ, Karlsmark T, Jorgensen B, Klein BM, Krogfelt KA. Multiple bacterial species reside in chronic wounds: a longitudinal study. Int. Wound J. 3(3), 225-231 (2006).
94. Halbert AR, Stacey MC, Rohr JB, Jopp-McKay A. The effect of bacterial colonization on venous ulcer healing. Aus. J. Dermatol. 33(2), 75-80 (1992).
95. Madsen SM, Westh H, Danielsen L, Rosdahl VT. Bacterial colonization and healing of venous leg ulcers. APMIS 104(12), 895-899 (1996).
96. Hogsberg T, Bjarnsholt T, Thomsen JS, Kirketerp-Moller K. Success rate of split-thickness skin grafting of chronic venous leg ulcers depends on the presence of Pseudomonas aeruginosa: a retrospective study. PLoS ONE 6(5), e20492 (2011).
97. Hall-Stoodley L, Stoodley P, Kathju S et al. Towards diagnostic guidelines for biofilm-associated infections. FEMS Immunol. Med. Microbiol. 65(2), 127-145 (2012).
98. Jensen PO, Givskov M, Bjarnsholt T, Moser C. The immune system vs. Pseudomonas aeruginosa biofilms. FEMS Immunol. Med. Microbiol. 59(3), 292-305 (2010).
99. Mah TF, O'Toole GA. Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol. 9(1), 34-39 (2001).
100. Donlan RM, Costerton JW. Biof: survival mechanisms of clinically relevant microorganisms. Clin. Microbiol. Rev. 15(2), 167-193 (2002).
101. Mah TF, Pitts B, Pellock B, Walker GC, Stewart PS, O'Toole GA. A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance. Nature 426(6964), 306-310 (2003).
102. Lewis K. Persister cells and the riddle of biofilm survival. Biochemistry (Mosc.) 70(2), 267-274 (2005).
103. del Pozo JL, Patel R. The challenge of treating biofilm-associated bacterial infections. Clin. Pharmacol. Ther. 82(2), 204-209 (2007).
104. Anderson GG, O'Toole GA. Innate and induced resistance mechanisms of bacterial biofilms. Curr. Topics Microbiol. Immunol. 322, 85-105 (2008).
105. Haussler S, Ziegler I, Lottel A et al. Highly adherent small-colony variants of Pseudomonas aeruginosa in cystic fibrosis lung infection. J. Med. Microbiol. 52(Pt 4), 295-301 (2003).
106. Haussler S, Tummler B, Weissbrodt H, Rohde M, Steinmetz I. Small-colony variants of Pseudomonas aeruginosa in cystic fibrosis. Clin. Infect. Dis. 29(3), 621-625 (1999).
107. Ramphal R, Lhermitte M, Filliat M, Roussel P. The binding of anti-pseudomonal antibiotics to macromolecules from cystic fibrosis sputum. J. Antimicrob. Chemother. 22(4), 483-490 (1988).
108. Hunt BE, Weber A, Berger A, Ramsey B, Smith AL. Macromolecular mechanisms of sputum inhibition of tobramycin activity. Antimicrob. Agents Chemother. 39(1), 34-39 (1995).
109. Purdy Drew KR, Sanders LK, Culumber ZW, Zribi O, Wong GC. Cationic amphiphiles increase activity of aminoglycoside antibiotic tobramycin in the presence of airway polyelectrolytes. J. Am. Chem. Soc. 131(2), 486-493 (2009).
110. Mulcahy H, Charron-Mazenod L, Lewenza S. Extracellular DNA chelates cations and induces antibiotic resistance in Pseudomonas aeruginosa biofilms. PLoS Pathog. 4(11), e1000213 (2008).
111. Chiang WC, Nilsson M, Jensen PO et al. Extracellular DNA shields against aminoglycosides in Pseudomonas aeruginosa biofilms. Antimicrob. Agents Chemother. 57(5), 2352-2361 (2013).
112. Nichols WW, Dorrington SM, Slack MP, Walmsley HL. Inhibition of tobramycin diffusion by binding to alginate. Antimicrob. Agents Chemother. 32(4), 518-523 (1988).
113. Bagge N, Schuster M, Hentzer M et al. Pseudomonas aeruginosa biofilms exposed to imipenem exhibit changes in global gene expression and b-lactamase and alginate production. Antimicrob. Agents Chemother. 48(4), 1175-1187 (2004).
114. Smith EE, Buckley DG, Wu Z et al. Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc. Natl Acad. Sci. USA 103(22), 8487-8492 (2006).
115. Kolpen M, Hansen CR, Bjarnsholt T et al. Polymorphonuclear leucocytes consume oxygen in sputum from chronic Pseudomonas aeruginosa pneumonia in cystic fibrosis. Thorax 65(1), 57-62 (2010).
116. Christensen LD, Moser C, Jensen PO et al. Impact of Pseudomonas aeruginosa quorum sensing on biofilm persistence in an in vivo intraperitoneal foreign-body infection model. Microbiology 153(Pt 7), 2312-2320 (2007).
117. Xiao G, Deziel E, He J et al. MvfR, a key Pseudomonas aeruginosa pathogenicity LTTR-class regulatory protein, has dual ligands. Mol. Microbiol. 62(6), 1689-1699 (2006).
118. Alhede M, Bjarnsholt T, Jensen PO et al. Pseudomonas aeruginosa recognizes and responds aggressively to the presence of polymorphonuclear leukocytes. Microbiology 155(Pt 11), 3500-3508 (2009).
119. Galloway WR, Hodgkinson JT, Bowden S, Welch M, Spring DR. Applications of small molecule activators and inhibitors of quorum sensing in Gram-negative bacteria. Trends Microbiol. 20(9), 449-458 (2012).
120. Hentzer M, Riedel K, Rasmussen TB et al. Inhibition of quorum sensing in Pseudomonas aeruginosa biofilm bacteria by a halogenated furanone compound. Microbiology 148(Pt 1), 87-102 (2002).
121. Garde C, Bjarnsholt T, Givskov M et al. Quorum sensing regulation in Aeromonas hydrophila. J. Mol. Biol. 396(4), 849-857 (2010).
122. Rasmussen TB, Bjarnsholt T, Skindersoe ME et al. Screening for quorum-sensing inhibitors (QSI) by use of a novel genetic system, the QSI selector. J. Bacteriol. 187(5), 1799-1814 (2005).
123. Bjarnsholt T, van Gennip M, Jakobsen TH, Christensen LD, Jensen PO, Givskov M. In vitro screens for quorum sensing inhibitors and in vivo confirmation of their effect. Nat. Protoc. 5(2), 282-293 (2010).
124. McClean KH, Winson MK, Fish L et al. Quorum sensing and Chromobacterium violaceum: exploitation of violacein production and inhibition for the detection of N-acylhomoserine lactones. Microbiology 143(Pt 12), 3703-3711 (1997).
125. Shaw PD, Ping G, Daly SL et al. Detecting and characterizing N-acyl-homoserine lactone signal molecules by thin-layer chromatography. Proc. Natl Acad. Sci. USA 94(12), 6036-6041 (1997).
126. Steindler L, Venturi V. Detection of quorum-sensing N-acyl homoserine lactone signal molecules by bacterial biosensors. FEMS Microbiol. Lett. 266(1), 1-9 (2007).
127. Massai F, Imperi F, Quattrucci S, Zennaro E, Visca P, Leoni L. A multitask biosensor for micro-volumetric detection of N-3-oxo-dodecanoyl- homoserine lactone quorum sensing signal. Biosens. Bioelectron. 26(8), 3444-3449 (2011).
128. Ortori CA, Atkinson S, Chhabra SR, Camara M, Williams P, Barrett DA. Comprehensive profiling of N-acylhomoserine lactones produced by Yersinia pseudotuberculosis using liquid chromatography coupled to hybrid quadrupole-linear ion trap mass spectrometry. Anal. Bioanal. Chem. 387(2), 497-511 (2007).
129. Fletcher MP, Diggle SP, Crusz SA, Chhabra SR, Camara M, Williams P. A dual biosensor for 2-alkyl-4-quinolone quorum-sensing signal molecules. Environ. Microbiol. 9(11), 2683-2693 (2007).
130. Fletcher MP, Diggle SP, Camara M, Williams P. Biosensor-based assays for PQS, HHQ and related 2-alkyl-4-quinolone quorum sensing signal molecules. Nat. Protoc. 2(5), 1254-1262 (2007).
131. Diggle SP, Fletcher MP, Camara M, Williams P. Detection of 2-alkyl-4-quinolones using biosensors. Methods Mol. Biol. 692, 21-30 (2011).
132. Yuan Y, Sachdeva M, Leeds JA, Meredith TC. Fatty acid biosynthesis in Pseudomonas aeruginosa is initiated by the FabY class of b-ketoacyl acyl carrier protein synthases. J. Bacteriol. 194(19), 5171-5184 (2012).
133. Givskov M, de Nys R, Manefield M et al. Eukaryotic interference with homoserine lactone-mediated prokaryotic signalling. J. Bacteriol. 178(22), 6618-6622 (1996).
134. Wu H, Song Z, Hentzer M et al. Synthetic furanones inhibit quorum-sensing and enhance bacterial clearance in Pseudomonas aeruginosa lung infection in mice. J. Antimicrob. Chemother. 53(6), 1054-1061 (2004).
135. Rasmussen TB, Skindersoe ME, Bjarnsholt T et al. Identity and effects of quorum-sensing inhibitors produced by Penicillium species. Microbiology 151(Pt 5), 1325-1340 (2005).
136. LaLonde RT, Bu L, Henwood A, Fiumano J, Zhang L. Bromine-, chlorine-, and mixed halogen-substituted 4-methyl-2(5H)-furanones: synthesis and mutagenic effects of halogen and hydroxyl group replacements. Chem. Res. Toxicol. 10(12), 1427-1436 (1997).
137. Janecki T, Blaszczyk E, Studzian K, Rozalski M, Krajewska U, Janecka A. New stereocontrolled synthesis and biological evaluation of 5-(1'-hydroxyalkyl)- 3-methylidenetetrahydro-2-furanones as potential cytotoxic agents. J. Med. Chem. 45(5), 1142-1145 (2002).
138. Kim Y, Nam NH, You YJ, Ahn BZ. Synthesis and cytotoxicity of 3,4-diaryl-2(5H)-furanones. Bioorg. Med. Chem. Lett. 12(4), 719-722 (2002).
139. Skindersoe ME, Ettinger-Epstein P, Rasmussen TB, Bjarnsholt T, de Nys R, Givskov M. Quorum sensing antagonism from marine organisms. Mar. Biotechnol. (NY) 10(1), 56-63 (2008).
140. Bjarnsholt T, Jensen PO, Rasmussen TB et al. Garlic blocks quorum sensing and promotes rapid clearing of pulmonary Pseudomonas aeruginosa infections. Microbiology 151(Pt 12), 3873-3880 (2005).
141. Jakobsen TH, van Gennip M, Phipps RK et al. Ajoene, a sulfur-rich molecule from garlic, inhibits genes controlled by quorum sensing. Antimicrob. Agents Chemother. 56(5), 2314-2325 (2012).
142. Jakobsen TH, Bragason SK, Phipps RK et al. Food as a source for quorum sensing inhibitors: iberin from horseradish revealed as a quorum sensing inhibitor of Pseudomonas aeruginosa. Appl. Environ. Microbiol. 78(7), 2410-2421 (2012).
143. Ganin H, Rayo J, Amara N, Levy N, Krief P, Meijler MM. Sulforaphane and erucin, natural isothiocyanates from broccoli, inhibit, bacterial quorum sensing. Med. Chem. Commun. 4, 175-179 (2013).
144. Amara N, Mashiach R, Amar D et al. Covalent inhibition of bacterial quorum sensing. J. Am. Chem. Soc. 131(30), 10610-10619 (2009).
145. Christensen LD, van Gennip M, Jakobsen TH et al. Synergistic antibacterial efficacy of early combination treatment with tobramycin and quorum-sensing inhibitors against Pseudomonas aeruginosa in an intraperitoneal foreign-body infection mouse model. J. Antimicrob. Chemother. 67(5), 1198-1206 (2012).
146. Brackman G, Cos P, Maes L, Nelis HJ, Coenye T. Quorum sensing inhibitors increase the susceptibility of bacterial biofilms to antibiotics in vitro and in vivo. Antimicrob. Agents Chemother. 55(6), 2655-2661 (2011).
147. Smyth AR, Cifelli PM, Ortori CA et al. Garlic as an inhibitor of Pseudomonas aeruginosa quorum sensing in cystic fibrosis-a pilot randomized controlled trial. Pediatr. Pulmonol. 45(4), 356-362 (2010).
148. Geske GD, O'Neill JC, Blackwell HE. Expanding dialogues: from natural autoinducers to non-natural analogues that modulate quorum sensing in Gram-negative bacteria. Chem. Soc. Rev. 37(7), 1432-1447 (2008).
149. Galloway WR, Hodgkinson JT, Bowden SD, Welch M, Spring DR. Quorum sensing in Gram-negative bacteria: small-molecule modulation of AHL and AI-2 quorum sensing pathways. Chem. Rev. 111(1), 28-67 (2011).
150. Bottomley MJ, Muraglia E, Bazzo R, Carfi A. Molecular insights into quorum sensing in the human pathogen Pseudomonas aeruginosa from the structure of the virulence regulator LasR bound to its autoinducer. J. Biol. Chem. 282(18), 13592-13600 (2007).
151. Yang L, Rybtke MT, Jakobsen TH et al. Computer-aided identification of recognized drugs as Pseudomonas aeruginosa quorum-sensing inhibitors. Antimicrob. Agents Chemother. 53(6), 2432-2443 (2009).
152. Skovstrup S, Le Quement ST, Hansen T et al. Identification of LasR ligands through a virtual screening approach. ChemMedChem 8(1), 157-163 (2013).
153. Annapoorani A, Umamageswaran V, Parameswari R, Pandian SK, Ravi AV. Computational discovery of putative quorum sensing inhibitors against LasR and RhlR receptor proteins of Pseudomonas aeruginosa. J. Comput. Aided Mol. Des. 26(9), 1067-1077 (2012).
154. Muh U, Schuster M, Heim R, Singh A, Olson ER, Greenberg EP. Novel Pseudomonas aeruginosa quorum-sensing inhibitors identified in an ultra-high-throughput screen. Antimicrob. Agents Chemother. 50(11), 3674-3679 (2006).
155. Skindersoe ME, Alhede M, Phipps R et al. Effects of antibiotics on quorum sensing in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 52(10), 3648-3663 (2008).
156. Perez-Martinez I, Haas D. Azithromycin inhibits expression of the GacA-dependent small RNAs RsmY and RsmZ in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 55(7), 3399-3405 (2011).
157. Hoffmann N, Lee B, Hentzer M et al. Azithromycin blocks quorum sensing and alginate polymer formation and increases the sensitivity to serum and stationary-growth-phase killing of Pseudomonas aeruginosa and attenuates chronic P. aeruginosa lung infection in Cftr-/-mice. Antimicrob. Agents Chemother. 51(10), 3677-3687 (2007).
158. Bala A, Kumar R, Harjai K. Inhibition of quorum sensing in Pseudomonas aeruginosa by azithromycin and its effectiveness in urinary tract infections. J. Med. Microbiol. 60(Pt 3), 300-306 (2011).
159. Kohler T, Guanella R, Carlet J, van Delden C. Quorum sensing-dependent virulence during Pseudomonas aeruginosa colonisation and pneumonia in mechanically ventilated patients. Thorax 65(8), 703-710 (2010).
160. van Delden C, Kohler T, Brunner-Ferber F, Francois B, Carlet J, Pechere JC. Azithromycin to prevent Pseudomonas aeruginosa ventilator-associated pneumonia by inhibition of quorum sensing: a randomized controlled trial. Intensive Care Med. 38(7), 1118-1125 (2012).
161. Imperi F, Massai F, Ramachandran Pillai C et al. New life for an old drug: the anthelmintic drug niclosamide inhibits Pseudomonas aeruginosa quorum sensing. Antimicrob. Agents Chemother. 57(2), 996-1005 (2013).
162. Calfee MW, Coleman JP, Pesci EC. Interference with Pseudomonas quinolone signal synthesis inhibits virulence factor expression by Pseudomonas aeruginosa. Proc. Natl Acad. Sci. USA 98(20), 11633-11637 (2001).
163. Lesic B, Lepine F, Deziel E et al. Inhibitors of pathogen intercellular signals as selective anti-infective compounds. PLoS Pathog. 3(9), 1229-1239 (2007).
164. Klein T, Henn C, de Jong JC et al. Identification of small-molecule antagonists of the Pseudomonas aeruginosa transcriptional regulator PqsR: biophysically guided hit discovery and optimization. ACS Chem. Biol. 7(9), 1496-1501 (2012).
165. Zaborina O, Lepine F, Xiao G et al. Dynorphin activates quorum sensing quinolone signaling in Pseudomonas aeruginosa. PLoS Pathog. 3(3), e35 (2007).
166. Storz MP, Maurer CK, Zimmer C et al. Validation of PqsD as an anti-biofilm target in Pseudomonas aeruginosa by development of small-molecule inhibitors. J. Am. Chem. Soc. 134(39), 16143-16146 (2012).
167. Lewis K. Persister cells, dormancy and infectious disease. Nat. Rev. Microbiol. 5(1), 48-56 (2007).
168. Fux CA, Stoodley P, Hall-Stoodley L, Costerton JW. Bacterial biofilms: a diagnostic and therapeutic challenge. Expert Rev. Anti. Infect. Ther. 1(4), 667-683 (2003).
169. Maeda T, Garcia-Contreras R, Pu M et al. Quorum quenching quandary: resistance to antivirulence compounds. ISME J. 6(3), 493-501 (2012).
170. Chen H, Yi C, Zhang J et al. Structural insight into the oxidation-sensing mechanism of the antibiotic resistance of regulator MexR. EMBO Rep. 11(9), 685-690 (2010).
171. Pearson JP, Van Delden C, Iglewski BH. Active efflux and diffusion are involved in transport of Pseudomonas aeruginosa cell-to-cell signals. J. Bacteriol. 181(4), 1203-1210 (1999).
172. Mellbye B, Schuster M. The sociomicrobiology of antivirulence drug resistance: a proof of concept. MBio 2(5), e00131-11 (2011).
173. Ciofu O, Mandsberg LF, Bjarnsholt T, Wassermann T, Hoiby N. Genetic adaptation of Pseudomonas aeruginosa during chronic lung infection of patients with cystic fibrosis: strong and weak mutators with heterogeneous genetic backgrounds emerge in mucA and/or lasR mutants. Microbiology 156(Pt 4), 1108-1119 (2010).
174. Folkesson A, Jelsbak L, Yang L et al. Adaptation of Pseudomonas aeruginosa to the cystic fibrosis airway: an evolutionary perspective. Nat. Rev. Microbiol. 10(12), 841-851 (2012).
175. Bjarnsholt T, Jensen PO, Jakobsen TH et al. Quorum sensing and virulence of Pseudomonas aeruginosa during lung infection of cystic fibrosis patients. PLoS ONE 5(4), e10115 (2010).
176. Bielecki P, Komor U, Bielecka A et al. Ex vivo transcriptional profiling reveals a common set of genes important for the adaptation of Pseudomonas aeruginosa to chronically infected host sites. Environ. Microbiol. 15(2), 570-587 (2013).
177. D'Argenio DA, Wu M, Hoffman LR et al. Growth phenotypes of Pseudomonas aeruginosa lasR mutants adapted to the airways of cystic fibrosis patients. Mol. Microbiol. 64(2), 512-533 (2007).
178. Heurlier K, Denervaud V, Haas D. Impact of quorum sensing on fitness of Pseudomonas aeruginosa. Int J. Med. Microbiol. 296(2-3), 93-102 (2006).
179. Schaber JA, Carty NL, McDonald NA et al. Analysis of quorum sensing-deficient clinical isolates of Pseudomonas aeruginosa. J. Med. Microbiol. 53(Pt 9), 841-853 (2004).
180. Erickson DL, Endersby R, Kirkham A et al. Pseudomonas aeruginosa quorum-sensing systems may control virulence factor expression in the lungs of patients with cystic fibrosis. Infect. Immun. 70(4), 1783-1790 (2002).
181. Middleton B, Rodgers HC, Camara M, Knox AJ, Williams P, Hardman A. Direct detection of N-acylhomoserine lactones in cystic fibrosis sputum. FEMS Microbiol. Lett. 207(1), 1-7 (2002).
182. Chambers CE, Visser MB, Schwab U, Sokol PA. Identification of N-acylhomoserine lactones in mucopurulent respiratory secretions from cystic fibrosis patients. FEMS Microbiol. Lett. 244(2), 297-304 (2005).
183. Singh PK, Schaefer AL, Parsek MR, Moninger TO, Welsh MJ, Greenberg EP. Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms. Nature 407(6805), 762-764 (2000).
184. Wilder CN, Allada G, Schuster M. Instantaneous within-patient diversity of Pseudomonas aeruginosa quorum-sensing populations from cystic fibrosis lung infections. Infect. Immun. 77(12), 5631-5639 (2009).
185. Diggle SP, Griffin AS, Campbell GS, West SA. Cooperation and conflict in quorum-sensing bacterial populations. Nature 450(7168), 411-414 (2007).
186. Kohler T, Buckling A, van Delden C. Cooperation and virulence of clinical Pseudomonas aeruginosa populations. Proc. Natl Acad. Sci. USA 106(15), 6339-6344 (2009).
187. Kohler T, Perron GG, Buckling A, van Delden C. Quorum sensing inhibition selects for virulence and cooperation in Pseudomonas aeruginosa. PLoS Pathog. 6(5), e1000883 (2010).
188. Musken M, Di Fiore S, Romling U, Haussler S. A 96-well-plate-based optical method for the quantitative and qualitative evaluation of Pseudomonas aeruginosa biofilm formation and its application to susceptibility testing. Nat. Protoc. 5(8), 1460-1469 (2010).